Capitalizing on cellular ‘housekeeping’ could help beat age-related diseases

brown mouse
Mice engineered to have high levels of autophagy are protected from age-related diseases like Alzheimer's. (Alexandra/München)

Scientists at UT Southwestern Medical School have spent the last two decades studying autophagy, the process cells use to throw out toxic substances that endanger their health. They discovered autophagy not only helps the body fight off infections, but it also protects against many age-related diseases such as cancer and neurological disorders.

The findings raised a question: Could boosting natural levels of autophagy be a safe way to improve health and extend life? A new study in mice, published in the journal Nature, suggests it might.

To answer the question, the researchers genetically engineered mice to have a mutation in a protein called beclin 1. The UT Southwestern team had previously discovered that the gene that makes this protein drives autophagy, and that mutating it prevents it from binding to an autophagy-inhibiting protein called Bcl-2. The mutation resulted in mice born with persistently high levels of autophagy.


How ICON, Lotus, and Bioforum are Improving Study Efficiency with a Modern EDC

CROs are often at the forefront of adopting new technologies to make clinical trials more efficient. Hear how ICON, Lotus Clinical Research, and Bioforum are speeding database builds and automating reporting tasks for data management.

The result: The animals lived 10% longer than normal mice and were less likely to develop heart disease, kidney problems and age-related cancer, according to a statement from the university.

RELATED: Scientists reveal secrets of ‘anti-aging’ hormones

The research builds on previous studies showing the genetically engineered mice seem to be protected against the natural decline in autophagy that occurs with age. A year ago, the UT Southwestern team reported that the engineered mice were less likely to develop Alzheimer’s disease.

In the new study, the scientists observed that mice with increased levels of autophagy are protected from the loss of klotho—a hormone that has been proven to regulate metabolism and longevity. Klotho is the target of several research programs aimed at combating diseases of aging, and it inspired the startup Klogene, which is working on new approaches to treating Alzheimer’s.

The next step for the UT Southwestern scientists is to develop drugs that disrupt the ability of beclin 1 to bind to Bcl-2, thereby increasing autophagy.

"These studies have important implications for human health and for the development of drugs to improve it," said Beth Levine, M.D., director of the Center for Autophagy Research at UT Southwestern, in the statement. "They show that strategies to increase the cellular housekeeping pathway of autophagy may retard aging and aging-related diseases.”

Suggested Articles

Janssen’s BCMA-targeting CAR-T therapy eliminated tumors in 69% of patients with advanced multiple myeloma in a small phase 1 study.

In a study, BMS' CAR-T therapy banished tumors in more than half and shrank tumors in nearly three-quarters of relapsed blood cancer patients.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.